Mode
Text Size
Log in / Sign up
Phase 4 N=82 Randomized Single-blind Treatment

iPACK for Post-op Pain Following ACL Reconstruction

ACL Injury · Post Operative Pain

Enrolled (actual)
82
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Pain Scores — 41.5; 29.8; 37.9; 47.4 units on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Adductor Canal Block (ACB) Only (Drug); Adductor Canal Block (ACB) + iPACK Block (Drug)
Age
Pediatric, Adult, Older Adult · 12+ yrs
Sex
All
Sponsor
Medical University of South Carolina
Primary completion
Jul 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Scores
41.5; 29.8; 37.9; 47.4; 38.7; 49.9
SECONDARY
Total Postoperative Opioid Consumption (Total MME)
8.26; 11.2; 6.09; 10.5; 10.4; 16.2
SECONDARY
Range of Motion (Degrees)
90.0; 99.3

Summary

This study will consist of patients 12 years and older undergoing ACL reconstruction using a quadriceps or bone-patella tendon bone (BTB) graft. The patients will be randomized to adductor canal block alone, or adductor canal block + iPACK block. The primary goal will be to determine the differences in postoperative pain during the first 72 hours when comparing the two groups. Secondary outcomes will include opioid utilization during the first 72 hours postoperatively and range of motion including terminal knee extension at postoperative follow-up visits.

Eligibility Criteria

Inclusion Criteria

  • Age 12 years and older
  • Patients who are scheduled to undergo an ACL reconstruction with quadriceps or BTB graft.

Exclusion Criteria

  • Any contraindication to receiving regional anesthesia. This may include infection at the site of injection, allergy to local anesthetic, or pre-existing nerve injury.
  • Patients undergoing hamstring graft or allograft for ACL
  • Pre-existing infection at the site of injury
  • Patients on chronic opioid treatments
  • Pre-existing sensory or motor deficit in operative extremity
  • Patients having a revision of previous ACL reconstruction
  • Pregnant and/or lactating women
  • Weighs less than 40kg
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05498870). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search